Jyong Biotech Debt to Equity Ratio 1971-1970 | MENS
Current and historical debt to equity ratio values for Jyong Biotech (MENS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Jyong Biotech debt/equity for the three months ending January 01, 1970 was 0.00.
| Jyong Biotech Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED-BIOMED/GENE | $0.693B | $0.000B |
| Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan. | |||